Immunotherapy plus chemo before surgery may keep head and neck cancer away longer
NCT ID NCT07371897
First seen Feb 01, 2026 · Last updated May 21, 2026 · Updated 16 times
Summary
This study tests two short treatments given before surgery for advanced head and neck cancer. One group gets an immunotherapy drug (toripalimab) alone, the other gets toripalimab plus two cycles of chemotherapy. After treatment, all patients have standard surgery and radiation. The goal is to see which approach better prevents the cancer from coming back. About 154 adults aged 18-70 with newly diagnosed, operable cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.